"Voted one of America's Top Docs and the Best Doctors in America, Dr. Schlessinger has also been consistently voted as the Best of Omaha Dermatologist and Cosmetic surgeon for more than 24 years. As a board certified dermatologist and general cosmetic surgeon in Omaha, Nebraska, Dr. Schlessinger has more than 30 years of experience treating a wide variety of skin conditions. Dr. Schlessinger is also the founder of the Schlessinger MD Skin Research Center, a clinical research facility that investigates new medications and treatments for a wide range of skin conditions and cosmetic procedures."

During the past decade, Skin Specialists PC (Schlessinger MD) conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Skin Specialists PC (Schlessinger MD)" #1 sponsor was "Kythera Biopharmaceuticals" with 2 trials, followed by "Aristea Therapeutics, Inc." with 1 trials sponsored, "CollaGenex Pharmaceuticals" with 1 trials sponsored, "Merz Pharmaceuticals GmbH" with 1 trials sponsored and "RAPT Therapeutics, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "Skin Specialists PC (Schlessinger MD)" are "Atopic Dermatitis" (1 trials), "Healthy" (1 trials), "Lipoma" (1 trials), "Moderate to Severe Glabellar Frown Lines" (1 trials) and "Palmoplantar Pustulosis" (1 trials). Many other conditions were trialed in "Skin Specialists PC (Schlessinger MD)" in a lesser frequency.

Most popular intervention types in "Skin Specialists PC (Schlessinger MD)" are "Drug" (6 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "ATX-101-BA" (1 trials), "ATX-101-BA-free" (1 trials), "Deoxycholic Acid Injection" (1 trials) and "IncobotulinumtoxinA (Xeomin) (20 Units)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Skin Specialists PC (Schlessinger MD)" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Skin Specialists PC (Schlessinger MD)". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Skin Specialists PC (Schlessinger MD), undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Skin Specialists PC (Schlessinger MD), 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".